Pharma

Belite Bio Announces Landmark Phase 3 Success for Stargardt Disease

Tinlarebant becomes the first therapy to show clinical benefit in a pivotal global trial, reducing retinal lesion growth by 36% and paving the way for a planned FDA filing in 2026.

Study Shows TREMFYA® Slows Psoriatic Arthritis Progression at 48 Weeks

Long-term APEX results reinforce TREMFYA® as the only IL-23 inhibitor proven to slow structural joint damage in psoriatic arthritis.

World-First Preventative Lung Cancer Vaccine Enters Clinical Trial

A groundbreaking clinical trial set to begin in summer 2026 will test LungVax, the world’s first vaccine designed to prevent lung cancer in people at high risk, a major milestone in cancer prevention research.

Optibrium Launches StarDrop 8, Bringing Real-Time Collaboration to Molecular Design

StarDrop 8 integrates real-time collaboration into compound design and optimisation, streamlining decision-making and improving team productivity.

Astellas Reports Long-Term Benefits and Strong Safety Profile for IZERVAY™ in Geographic Atrophy

GATHER2 extension data show sustained efficacy and no new safety concerns after 3.5 years of treatment.

Novo Nordisk Pulls Plug on Cell Therapy in $1.3B Restructuring Push

The pharma giant will close its cell therapy unit, cutting 250 jobs and ending work on Type 1 diabetes and Parkinson's programs, as new CEO shifts focus to obesity, diabetes, and liver disease treatments.